Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-12-15

FDA Approved: BENZNIDAZOLE — Supplemental Application (Exeltis USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for benznidazole by Exeltis USA, Inc., indicating an approved update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benznidazole (benznidazole)

Snippet

SUPPL AP for BENZNIDAZOLE (BENZNIDAZOLE)